StockData
Axogen, Inc. logo

Axogen, Inc. (AXGN) stock

AXGNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/30142% above fair value
$56.95+1.58 (+2.85%)

Close on Nov 18, 2026Market cap $3.40BP/E –Yield –

Axogen revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Axogen's revenue for the twelve months ending Sep 30, 2026 was $266.93M, up 24.3% year over year. For fiscal 2025 it was $225.21M, up 20.2% from the year before. Over ten years it grew 23.5% a year on average. The highest annual figure on record is $225.21M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$225.21M+20.2%
FY2024Dec 31, 2024$187.34M+17.8%
FY2023Dec 31, 2023$159.01M+14.7%
FY2022Dec 31, 2022$138.58M+8.8%
FY2021Dec 31, 2021$127.36M+13.4%
FY2020Dec 31, 2020$112.30M+5.2%
FY2019Dec 31, 2019$106.71M+27.1%
FY2018Dec 31, 2018$83.94M+38.9%
FY2017Dec 31, 2017$60.43M+47.0%
FY2016Dec 31, 2016$41.11M+50.4%
FY2015Dec 31, 2015$27.33M+62.5%
FY2014Dec 31, 2014$16.82M+53.6%
FY2013Dec 31, 2013$10.95M+42.3%
FY2012Dec 31, 2012$7.69M+58.6%
FY2011Dec 31, 2011$4.85M+61.4%
FY2010Dec 31, 2010$3.00M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$75.83M+26.2%
Q2 FY2026Jun 30, 2026$69.73M+23.1%
Q1 FY2026Mar 31, 2026$61.46M+26.6%
Q4 FY2025Dec 31, 2025$59.90M+21.3%
Q3 FY2025Sep 30, 2025$60.08M+23.5%
Q2 FY2025Jun 30, 2025$56.66M+18.3%
Q1 FY2025Mar 31, 2025$48.56M+17.4%
Q4 FY2024Dec 31, 2024$49.41M+15.1%
Q3 FY2024Sep 30, 2024$48.64M+17.9%
Q2 FY2024Jun 30, 2024$47.91M+25.6%
Q1 FY2024Mar 31, 2024$41.38M+12.9%
Q4 FY2023Dec 31, 2023$42.92M+18.7%
Q3 FY2023Sep 30, 2023$41.27M+11.7%
Q2 FY2023Jun 30, 2023$38.16M+10.7%
Q1 FY2023Mar 31, 2023$36.66M+18.2%
Q4 FY2022Dec 31, 2022$36.16M+14.7%
Q3 FY2022Sep 30, 2022$36.96M+18.4%
Q2 FY2022Jun 30, 2022$34.45M+2.6%
Q1 FY2022Mar 31, 2022$31.01M-0.1%
Q4 FY2021Dec 31, 2021$31.54M-2.9%
Q3 FY2021Sep 30, 2021$31.20M-6.7%
Q2 FY2021Jun 30, 2021$33.58M+51.8%
Q1 FY2021Mar 31, 2021$31.04M+27.9%
Q4 FY2020Dec 31, 2020$32.50M+15.4%
Q3 FY2020Sep 30, 2020$33.43M+17.0%
Q2 FY2020Jun 30, 2020$22.12M-17.2%
Q1 FY2020Mar 31, 2020$24.26M+4.2%
Q4 FY2019Dec 31, 2019$28.16M+20.2%
Q3 FY2019Sep 30, 2019$28.56M+26.1%
Q2 FY2019Jun 30, 2019$26.70M+29.7%
Q1 FY2019Mar 31, 2019$23.29M+34.9%
Q4 FY2018Dec 31, 2018$23.43M+38.1%
Q3 FY2018Sep 30, 2018$22.66M+41.2%
Q2 FY2018Jun 30, 2018$20.58M+35.7%
Q1 FY2018Mar 31, 2018$17.26M+41.0%
Q4 FY2017Dec 31, 2017$16.97M+48.8%
Q3 FY2017Sep 30, 2017$16.05M–
Q2 FY2017Jun 30, 2017$15.17M–
Q1 FY2017Mar 31, 2017$12.24M–
Q4 FY2016Dec 31, 2016$11.41M–

More Axogen figures

See a number that looks wrong?